Needham & Company Increases Medidata Solutions Price Target to $135.00 (MDSO)
Research analysts at Needham & Company boosted their price objective on shares of Medidata Solutions (NASDAQ:MDSO) from $92.00 to $135.00 in a report released on Friday, Stock Ratings News reports. The firm currently has a “buy” rating on the stock. Needham & Company’s target price indicates a potential upside of 14.18% from the stock’s previous close.
A number of other analysts have also recently weighed in on MDSO. Analysts at Jefferies Group reiterated a “buy” rating on shares of Medidata Solutions in a research note to investors on Friday. They now have a $145.00 price target on the stock, up previously from $105.00. Separately, analysts at B. Riley raised their price target on shares of Medidata Solutions from $75.00 to $93.00 in a research note to investors on Tuesday. They now have a “neutral” rating on the stock. Finally, analysts at Credit Suisse raised their price target on shares of Medidata Solutions from $94.00 to $108.00 in a research note to investors on Friday, September 13th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $99.73.
Medidata Solutions (NASDAQ:MDSO) opened at 118.23 on Friday. Medidata Solutions has a one year low of $31.30 and a one year high of $99.79. The stock’s 50-day moving average is $89.9 and its 200-day moving average is $71.32. The company has a market cap of $3.035 billion and a P/E ratio of 148.67.
Medidata Solutions (NASDAQ:MDSO) last released its earnings data on Thursday, October 24th. The company reported $0.40 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.33 by $0.07. The company had revenue of $70.90 million for the quarter, compared to the consensus estimate of $70.74 million. During the same quarter in the prior year, the company posted $0.29 earnings per share. The company’s quarterly revenue was up 27.1% on a year-over-year basis. Analysts expect that Medidata Solutions will post $1.39 EPS for the current fiscal year.
Medidata Solutions, Inc (NASDAQ:MDSO) is a global provider of software-as-a-service (SaaS), clinical technology solutions.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.